Originally published byEU-Startups
Alcolase, a Copenhagen-based BioTech startup tackling alcohol intolerance by providing remedies for alcohol flush, today announced a €1.5 million funding round supported by Ada Ventures, Delphinus Venture Capital, Antler, Manigoff Invest and a group of business angels. The company plans to first enter the Singapore market, followed by South Korea, where alcohol intolerance is more […]
The post Copenhagen’s Alcolase secures €1.5 million to develop enzyme-based remedy for alcohol flush appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Europe’s AI future depends on UK-France-Germany DARPA alliance, says Nobel winner
16h ago
Earlybird raising €500m defence fund with French investor AVP, sources say
3h ago
Paris-based Prelude raises €17.2 million Series A to scale its onboarding and trust infrastructure platform
1d ago
London’s Searchable raises €11.9 million at €72.1 million valuation to help brands boost visibility across AI-led search
12h ago
Could Europe’s Red Tape finally be its Biggest Moat?
2d ago